Leonie Haverkamp

About

Leonie Haverkamp is a pioneering surgeon whose work has reshaped the landscape of esophageal cancer treatment. Her primary research focus lies in advancing minimally invasive surgical techniques, specifically robot-assisted minimally invasive thoraco-laparoscopic esophagectomy (RAMIE). Haverkamp’s major contribution is leading the landmark ROBOT trial, a randomized controlled trial that demonstrated RAMIE’s superiority over open transthoracic esophagectomy, showing reduced blood loss and shorter ICU stays. This work, cited 179 times, has been instrumental in establishing RAMIE as a viable, less invasive alternative to the traditional gold standard. Her subsequent research, with 151 citations, confirmed the oncologic long-term safety of RAMIE, proving it does not compromise cancer control. With over 230 total citations, Haverkamp’s influence extends to global practice, as evidenced by her 2023 survey tracking worldwide surgical trends. Her work not only improves patient recovery but also sets a new benchmark for precision in esophagectomy, making her a leading voice in the evolution of surgical oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)

   179 citations · 2012
2. 2
   Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer

   151 citations · 2015
3. 3
   Surgical treatments for esophageal cancers

   56 citations · 2014
4. 4
   Trends in surgical techniques for the treatment of esophageal and gastroesophageal junction cancer: the 2022 update

   24 citations · 2023

Key Collaborators

Contact & Links